245 related articles for article (PubMed ID: 8616848)
1. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal.
Briand P; Nielsen KV; Madsen MW; Petersen OW
Cancer Res; 1996 May; 56(9):2039-44. PubMed ID: 8616848
[TBL] [Abstract][Full Text] [Related]
2. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
[TBL] [Abstract][Full Text] [Related]
3. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
4. Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.
Minke JM; Schuuring E; van den Berghe R; Stolwijk JA; Boonstra J; Cornelisse C; Hilkens J; Misdorp W
Cancer Res; 1991 Aug; 51(15):4028-37. PubMed ID: 1649697
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
Nass SJ; Dickson RB
Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
[TBL] [Abstract][Full Text] [Related]
6. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
7. Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium.
Petersen OW; van Deurs B; Nielsen KV; Madsen MW; Laursen I; Balslev I; Briand P
Cancer Res; 1990 Feb; 50(4):1257-70. PubMed ID: 2153455
[TBL] [Abstract][Full Text] [Related]
8. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
[TBL] [Abstract][Full Text] [Related]
9. Trisomy of rat chromosome 1 associated with mesothelial cell transformation.
Funaki K; Everitt J; Bermudez E; Walker C
Cancer Res; 1991 Aug; 51(15):4059-66. PubMed ID: 1855220
[TBL] [Abstract][Full Text] [Related]
10. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells.
Radinsky R; Risin S; Fan D; Dong Z; Bielenberg D; Bucana CD; Fidler IJ
Clin Cancer Res; 1995 Jan; 1(1):19-31. PubMed ID: 9815883
[TBL] [Abstract][Full Text] [Related]
11. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
Fujii K; Furukawa F; Matsuyoshi N
Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.
Bögler O; Nagane M; Gillis J; Huang HJ; Cavenee WK
Cell Growth Differ; 1999 Feb; 10(2):73-86. PubMed ID: 10074901
[TBL] [Abstract][Full Text] [Related]
14. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG; Hosick HL; Ethier SP
J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor stimulation of human breast cancer cells in culture.
Osborne CK; Hamilton B; Titus G; Livingston RB
Cancer Res; 1980 Jul; 40(7):2361-6. PubMed ID: 6966967
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
17. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
18. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
20. A novel human cell culture model for the study of familial prostate cancer.
Yasunaga Y; Nakamura K; Ewing CM; Isaacs WB; Hukku B; Rhim JS
Cancer Res; 2001 Aug; 61(16):5969-73. PubMed ID: 11507036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
